Precigen (PGEN) Short term Debt (2012 - 2023)
Precigen (PGEN) posted quarterly Short term Debt of $13.8 million for Q1 2023, up 8326.22% year-over-year from $164000.0 in Q1 2022, and down 68.03% quarter-over-quarter from $43.2 million in Q4 2022.
Precigen (PGEN) Short term Debt (2012 - 2023) Analysis & Trends
Precigen (PGEN) has reported Short term Debt for 12 consecutive years, with $13.8 million the latest figure, recorded in Q1 2023.
- In Q1 2023, Short term Debt rose 8326.22% year-over-year to $13.8 million; the TTM figure through Mar 2023 stood at $13.8 million (up 8326.22% YoY), while the FY2022 annual figure was $43.2 million, up 58304.05% from the prior year.
- Short term Debt slipped to $13.8 million in Q1 2023 per PGEN's latest filing, from $43.2 million in the prior quarter.
- Across five years, Short term Debt topped out at $82.1 million in Q3 2022 and bottomed at $19000.0 in Q4 2020.
- Historically, Short term Debt has averaged $8.9 million across 5 years, with a median of $169500.0 in 2020.
- Annual changes were most pronounced in 2020 — Short term Debt plunged 93.31% — and 2022, when it surged 58304.05%.
- Precigen's Short term Debt stood at $51000.0 in 2019, then tumbled by 62.75% to $19000.0 in 2020, then jumped by 289.47% to $74000.0 in 2021, then soared by 58304.05% to $43.2 million in 2022, then tumbled by 68.03% to $13.8 million in 2023.
- Business Quant data shows PGEN's Short term Debt at $13.8 million in Q1 2023, $43.2 million in Q4 2022, and $82.1 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 13.82 Mn |
| Dec 31, 2022 | 43.22 Mn |
| Sep 30, 2022 | 82.07 Mn |
| Jun 30, 2022 | 277,000.00 |
| Mar 31, 2022 | 164,000.00 |
| Dec 31, 2021 | 74,000.00 |
| Sep 30, 2021 | 355,000.00 |
| Jun 30, 2021 | 356,000.00 |
| Mar 31, 2021 | 52,000.00 |
| Dec 31, 2020 | 19,000.00 |
| Jun 30, 2020 | 175,000.00 |
| Mar 31, 2020 | 139,000.00 |
| Dec 31, 2019 | 51,000.00 |
| Sep 30, 2019 | 44,000.00 |
| Jun 30, 2019 | 74,000.00 |
| Mar 31, 2019 | 2.08 Mn |
| Dec 31, 2018 | 479,000.00 |
| Sep 30, 2018 | 143,000.00 |
| Jun 30, 2018 | 489,000.00 |
| Mar 31, 2018 | 501,000.00 |